Assessments of Patient and Patient Advocate Experience with the FDA For Patients Website, Patient Listening Sessions, and Patient Affairs Staff Inquiry System

Appendix IV: PAS Inquiry System

Feedback Survey

PRA Statement

OMB Control No. 0910-0697

Expiration Date: 12/31/2020        

According to the Paperwork Reduction Act of 1995, an agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a valid OMB control number.  The valid OMB control for this information collection is 0910-0697 and the expiration date is 12/31/2020. The time required to complete this information collection is estimated to average 5 minutes per response, including the time for reviewing instructions and completing and reviewing the collection of information.

Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestion for reducing burden to [email protected].

Your participation/nonparticipation is completely voluntary, and your responses will not have an effect on your eligibility for receipt of any FDA services. In instances where respondent identity is needed (e.g., for follow-up of non-responders), this information collection fully complies with all aspects of the Privacy Act and data will be kept secure to the fullest extent allowed by law.

Survey (5 min)

1. How would you rate your overall experience using the webform?

2. Is the purpose of the webform clear?

3. Is it clear who should complete the form (e.g., patients, researchers, doctors etc.)?

4. What questions or words were hard to understand?

5. How can the webform be better?

6. How would you go about asking a question to the FDA (e.g., Google, www.fda.gov, friend, etc.)

7. If this webform was put on www.fda.gov what type of questions would you ask the FDA?

8. Any other comments or suggestions?